(EXK) Endeavour Silver - Overview
Stock: Silver, Gold, Precious Metals
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 81.4% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.64 |
| Alpha | 155.17 |
| Character TTM | |
|---|---|
| Beta | 1.253 |
| Beta Downside | 1.146 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.56% |
| CAGR/Max DD | 0.80 |
Description: EXK Endeavour Silver January 14, 2026
Endeavour Silver Corp. (NYSE: EXK) is a vertically integrated miner that acquires, explores, develops, extracts, processes, refines, and reclaims silver-focused mineral assets across Mexico, Chile, Peru, and the United States. The firm’s portfolio includes the primary operating mines of La Colorada (Mexico) and the newly acquired Guanajuato-Silver (Mexico), together delivering roughly 12 million ounces of silver equivalent per year, with a secondary focus on gold and polymetallic by-products.
Key performance indicators that investors watch include a cash cost of approximately $7-$9 per ounce of silver (2023 average) and a net debt-to-EBITDA ratio near 0.7×, indicating modest leverage. The company’s earnings are highly sensitive to the spot silver price, which is driven by industrial demand (e.g., photovoltaics, electronics) and investment inflows, while macro-economic factors such as real-interest-rate differentials and U.S. dollar strength act as primary price levers. Recent sector trends show a 15 % YoY increase in global silver consumption for renewable-energy applications, bolstering the long-term demand outlook for Endeavour’s product mix.
For a deeper, data-driven assessment of EXK’s valuation and risk profile, a quick look at ValueRay’s analyst toolkit can help you surface the most material drivers and comparable peer metrics.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -93.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA 13.28 > 1.0 |
| NWC/Revenue: -16.98% < 20% (prev 13.00%; Δ -29.99% < -1%) |
| CFO/TA 0.05 > 3% & CFO 47.1m > Net Income -93.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (291.4m) vs 12m ago 18.44% < -2% |
| Gross Margin: 9.32% > 18% (prev 0.18%; Δ 914.2% > 0.5%) |
| Asset Turnover: 40.54% > 50% (prev 36.95%; Δ 3.59% > 0%) |
| Interest Coverage Ratio: -39.17 > 6 (EBITDA TTM -24.5m / Interest Expense TTM 2.02m) |
Altman Z'' -1.47
| A: -0.06 (Total Current Assets 207.9m - Total Current Liabilities 264.0m) / Total Assets 1.02b |
| B: -0.46 (Retained Earnings -467.5m / Total Assets 1.02b) |
| C: -0.10 (EBIT TTM -79.1m / Avg Total Assets 814.2m) |
| D: 0.99 (Book Value of Equity 504.0m / Total Liabilities 508.2m) |
| Altman-Z'' Score: -1.47 = CCC |
Beneish M -1.11
| DSRI: 2.77 (Receivables 79.0m/19.5m, Revenue 330.1m/225.9m) |
| GMI: 1.89 (GM 9.32% / 17.57%) |
| AQI: 0.10 (AQ_t 0.01 / AQ_t-1 0.11) |
| SGI: 1.46 (Revenue 330.1m / 225.9m) |
| TATA: -0.14 (NI -93.8m - CFO 47.1m) / TA 1.02b) |
| Beneish M-Score: -1.11 (Cap -4..+1) = D |
What is the price of EXK shares?
Over the past week, the price has changed by +3.93%, over one month by +7.17%, over three months by +55.19% and over the past year by +177.75%.
Is EXK a buy, sell or hold?
- StrongBuy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EXK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.2 | 15.9% |
| Analysts Target Price | 13.2 | 15.9% |
| ValueRay Target Price | 12.5 | 9.9% |
EXK Fundamental Data Overview February 07, 2026
P/S = 9.1097
P/B = 6.8687
Revenue TTM = 330.1m USD
EBIT TTM = -79.1m USD
EBITDA TTM = -24.5m USD
Long Term Debt = 114.8m USD (from longTermDebt, last quarter)
Short Term Debt = 13.3m USD (from shortTermDebt, last quarter)
Debt = 128.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 71.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.14b USD (3.07b + Debt 128.1m - CCE 57.0m)
Interest Coverage Ratio = -39.17 (Ebit TTM -79.1m / Interest Expense TTM 2.02m)
EV/FCF = -24.33x (Enterprise Value 3.14b / FCF TTM -129.1m)
FCF Yield = -4.11% (FCF TTM -129.1m / Enterprise Value 3.14b)
FCF Margin = -39.13% (FCF TTM -129.1m / Revenue TTM 330.1m)
Net Margin = -28.43% (Net Income TTM -93.8m / Revenue TTM 330.1m)
Gross Margin = 9.32% ((Revenue TTM 330.1m - Cost of Revenue TTM 299.3m) / Revenue TTM)
Gross Margin QoQ = 1.78% (prev 8.74%)
Tobins Q-Ratio = 3.09 (Enterprise Value 3.14b / Total Assets 1.02b)
Interest Expense / Debt = 0.53% (Interest Expense 676.4k / Debt 128.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -62.5m (EBIT -79.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.79 (Total Current Assets 207.9m / Total Current Liabilities 264.0m)
Debt / Equity = 0.25 (Debt 128.1m / totalStockholderEquity, last quarter 508.8m)
Debt / EBITDA = -2.90 (negative EBITDA) (Net Debt 71.0m / EBITDA -24.5m)
Debt / FCF = -0.55 (negative FCF - burning cash) (Net Debt 71.0m / FCF TTM -129.1m)
Total Stockholder Equity = 493.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.52% (Net Income -93.8m / Total Assets 1.02b)
RoE = -19.01% (Net Income TTM -93.8m / Total Stockholder Equity 493.6m)
RoCE = -13.00% (EBIT -79.1m / Capital Employed (Equity 493.6m + L.T.Debt 114.8m))
RoIC = -10.07% (negative operating profit) (NOPAT -62.5m / Invested Capital 620.4m)
WACC = 10.13% (E(3.07b)/V(3.20b) * Re(10.53%) + D(128.1m)/V(3.20b) * Rd(0.53%) * (1-Tc(0.21)))
Discount Rate = 10.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.38%
Fair Price DCF = unknown (Cash Flow -129.1m)
EPS Correlation: -36.53 | EPS CAGR: -10.99% | SUE: -1.72 | # QB: 0
Revenue Correlation: 55.52 | Revenue CAGR: 31.57% | SUE: -0.93 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.06 | Chg30d=-0.070 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.98 | Chg30d=+0.226 | Revisions Net=-1 | Growth EPS=+4786.8% | Growth Revenue=+81.2%